Critical Care

official impact factor 4.60

Commentary

Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?

Christian Storm and Achim Jörres*

Critical Care 2008, 12:193 doi:10.1186/cc7083

No comments have yet been made on this article.

Post a comment